Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Magali De Sauvage"'
Autor:
Scott L. Carter, Priscilla K. Brastianos, Ryan J. Sullivan, Mario L. Suvà, Arlene H. Sharpe, Michael A. Davies, Benjamin Izar, Genevieve Marie Boland, Daniel P. Cahill, Bob Carter, William T. Curry, Brian V. Nahed, Elizabeth Gerstner, Nancy Wang, Matthew Frosch, Maria Martinez-Lage, McKenzie Shaw, Christine Hebert, Dennie T. Frederick, Brian C. Miller, Kristen E. Pauken, Osmaan Shahid, Michael White, Husain Danish, Swaminathan Kumar, Aarushi Jain, Megha Subramanian, Alexander Kaplan, Brian Shaw, Mia Bertalan, Corey M. Gill, Benjamin M. Kuter, Robert H. Klein, Andrew W. Navia, Joana L. Mora, Juliana M. Larson, Ashish Dahal, Magali de Sauvage, Albert E. Kim, Matthew R. Strickland, Matt Lastrapes, Naema Nayyar, Jackson H. Stocking, Samuel C. Markson, Christopher Alvarez-Breckenridge
Melanoma-derived brain metastases (MBM) represent an unmet clinical need because central nervous system progression is frequently an end stage of the disease. Immune checkpoint inhibitors (ICI) provide a clinical opportunity against MBM; however, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00f17c2d9eaeb2bd5b784cdd4cccee44
https://doi.org/10.1158/2326-6066.c.6550955.v1
https://doi.org/10.1158/2326-6066.c.6550955.v1
Autor:
Scott L. Carter, Priscilla K. Brastianos, Ryan J. Sullivan, Mario L. Suvà, Arlene H. Sharpe, Michael A. Davies, Benjamin Izar, Genevieve Marie Boland, Daniel P. Cahill, Bob Carter, William T. Curry, Brian V. Nahed, Elizabeth Gerstner, Nancy Wang, Matthew Frosch, Maria Martinez-Lage, McKenzie Shaw, Christine Hebert, Dennie T. Frederick, Brian C. Miller, Kristen E. Pauken, Osmaan Shahid, Michael White, Husain Danish, Swaminathan Kumar, Aarushi Jain, Megha Subramanian, Alexander Kaplan, Brian Shaw, Mia Bertalan, Corey M. Gill, Benjamin M. Kuter, Robert H. Klein, Andrew W. Navia, Joana L. Mora, Juliana M. Larson, Ashish Dahal, Magali de Sauvage, Albert E. Kim, Matthew R. Strickland, Matt Lastrapes, Naema Nayyar, Jackson H. Stocking, Samuel C. Markson, Christopher Alvarez-Breckenridge
Supplementary Figure from Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::511e81039a40c6df92ccce5b50a7030e
https://doi.org/10.1158/2326-6066.22545491.v1
https://doi.org/10.1158/2326-6066.22545491.v1
Autor:
Scott L. Carter, Priscilla K. Brastianos, Ryan J. Sullivan, Mario L. Suvà, Arlene H. Sharpe, Michael A. Davies, Benjamin Izar, Genevieve Marie Boland, Daniel P. Cahill, Bob Carter, William T. Curry, Brian V. Nahed, Elizabeth Gerstner, Nancy Wang, Matthew Frosch, Maria Martinez-Lage, McKenzie Shaw, Christine Hebert, Dennie T. Frederick, Brian C. Miller, Kristen E. Pauken, Osmaan Shahid, Michael White, Husain Danish, Swaminathan Kumar, Aarushi Jain, Megha Subramanian, Alexander Kaplan, Brian Shaw, Mia Bertalan, Corey M. Gill, Benjamin M. Kuter, Robert H. Klein, Andrew W. Navia, Joana L. Mora, Juliana M. Larson, Ashish Dahal, Magali de Sauvage, Albert E. Kim, Matthew R. Strickland, Matt Lastrapes, Naema Nayyar, Jackson H. Stocking, Samuel C. Markson, Christopher Alvarez-Breckenridge
Supplementary Data from Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df63ea6b992a9c1526e21ec65ba3323
https://doi.org/10.1158/2326-6066.22545509
https://doi.org/10.1158/2326-6066.22545509
Autor:
Christopher Alvarez-Breckenridge, Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matt Lastrapes, Matthew R. Strickland, Albert E. Kim, Magali de Sauvage, Ashish Dahal, Juliana M. Larson, Joana L. Mora, Andrew W. Navia, Robert H. Klein, Benjamin M. Kuter, Corey M. Gill, Mia Bertalan, Brian Shaw, Alexander Kaplan, Megha Subramanian, Aarushi Jain, Swaminathan Kumar, Husain Danish, Michael White, Osmaan Shahid, Kristen E. Pauken, Brian C. Miller, Dennie T. Frederick, Christine Hebert, McKenzie Shaw, Maria Martinez-Lage, Matthew Frosch, Nancy Wang, Elizabeth Gerstner, Brian V. Nahed, William T. Curry, Bob Carter, Daniel P. Cahill, Genevieve Marie Boland, Benjamin Izar, Michael A. Davies, Arlene H. Sharpe, Mario L. Suvà, Ryan J. Sullivan, Priscilla K. Brastianos, Scott L. Carter
Publikováno v:
Cancer Immunol Res
Melanoma-derived brain metastases (MBM) represent an unmet clinical need because central nervous system progression is frequently an end stage of the disease. Immune checkpoint inhibitors (ICI) provide a clinical opportunity against MBM; however, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20edbdce0d8007b51c4ae75d9cb53333
https://europepmc.org/articles/PMC10201927/
https://europepmc.org/articles/PMC10201927/
Autor:
Scott L. Carter, Juan Carlos Martinez-Gutierrez, Tracy T. Batchelor, Ibiayi Dagogo-Jack, Christopher Alvarez-Breckenridge, Priscilla K. Brastianos, Sun Ha Paek, Michael White, Benjamin Kaufman, Kaitlin Hoang, Nicholas D. Camarda, Daniel P. Cahill, Megan R. D'Andrea, Anna S. Berghoff, Mia Bertalan, Parker H. Merrill, Darrell R. Borger, Sun Hye Park, Devin McCabe, Sandro Santagata, Deepika Nagabhushan, Franziska M. Ippen, A. John Iafrate, Matthew R. Strickland, Ryan P. Frazier, Naema Nayyar, Matthew Lastrapes, Ivanna Bihun, Emily Batchelor, Elisa Aquilanti, Maria Martinez-Lage, Brandyn A. Castro, Ben Kuter, Matthias Preusser, Matthew P. Frosch, Magali De Sauvage, David Shih, Andrew Kaneb, Bruce E. Johnson, Alexander Kaplan, Ugonma Chukwueke, Elizabeth R. Gerstner, Corey M. Gill
Publikováno v:
Nature Genetics. 52:371-377
Brain metastases from lung adenocarcinoma (BM-LUAD) frequently cause patient mortality. To identify genomic alterations that promote brain metastases, we performed whole-exome sequencing of 73 BM-LUAD cases. Using case-control analyses, we discovered
Autor:
Manmeet S. Ahluwalia, Yesne Alici, Deborah Allen, Brian M. Andersen, Joachim M. Baehring, Onyinye Balogun, Taylor Beal, Richard Douglas Beegle, Ankush Bhatia, Rachel Boutte, Priscilla K. Brastianos, Julia Brechbeil, William S. Breitbart, Toni Cao, Alan Carver, Marc C. Chamberlain, Samuel T. Chao, Eloise Chapman-Davis, Zhi-Jian Chen, Nathan Cherny, Ashish Dahal, Mark A. Damante, Annick Desjardins, Karan S. Dixit, Sean Dodson, J. Bradley Elder, Marc S. Ernstoff, Camilo E. Fadul, Shannon Fortin Ensign, Ashley Ghiaseddin, Sarah Goldberg, David Gritsch, Craig Horbinski, Jana Ivanidze, Larry Junck, Jeffrey M. Katz, Leon D. Kaulen, Moh'd Khushman, Cassie Kline, Priya Kumthekar, Mark Kurzrok, Autumn Lanoye, Juliana Larson, Eudocia Q. Lee, Denise Leung, Angela Liou, Simon S. Lo, Ashlee R. Loughan, Benjamin Lu, Rimas V. Lukas, Mark G. Malkin, Jacob Mandel, Kaitlyn Melnick, Jennifer Moliterno, Maciej M. Mrugala, Sabine Mueller, Erin S. Murphy, John Vincent Murray, Herbert B. Newton, Evan K. Noch, Barbara J. O’Brien, Patrick O’Shea, Eseosa Odigie, Alexander C. Ou, Nina A. Paleologos, Susan C. Pannullo, Kester A. Phillips, Alberto Picca, Alyx B. Porter, Amy A. Pruitt, Dimitri Psimaras, Yasmeen Rauf, Scott Ravyts, David A. Reardon, Varalakshmi Ballur Narayana Reddy, Morgan Reid, Maricruz Rivera, Anthony Rosenberg, Amber Nicole Ruiz, Magali de Sauvage, Shreya Saxena, David Schiff, David Shin, Seema Shroff, Karanvir Singh, Mohini Singh, Prathusan Subramaniam, John H. Suh, Ashley L. Sumrall, Lynne P. Taylor, Jigisha P. Thakkar, Joshua L. Wang, Patrick Y. Wen, Timothy G. White, Kelcie Willis, Jean-Paul Wolinsky, Kailin Yang, Lalanthica V. Yogendran, Gilbert Youssef, Michael N. Youssef, Zhen Ni Zhou, Alicia M. Zukas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17ca7d9f31ae8eb071484718149186e8
https://doi.org/10.1016/b978-0-12-821976-8.09988-6
https://doi.org/10.1016/b978-0-12-821976-8.09988-6
Autor:
Magali de Sauvage, Naema Nayyar, Consuelo Torrini, Edwin Nieblas-Bedolla, Priscilla Brastianos
Publikováno v:
Neuro-Oncology. 24:vii99-vii99
BACKGROUND Immune checkpoint inhibitors (ICI) have revolutionized the landscape of cancer treatment, including brain metastases. However, only a subset of patients with brain metastases respond to ICI. Activating mutations in the mitogen-activated pr
Autor:
Christopher Alvarez-Breckenridge, Mario L. Suvà, Aarushi Jain, Matthew Lastrapes, Arlene H. Sharpe, Bob S. Carter, Juliana M Larson, Christine Herbert, Swaminathan Kumar, Daniel P. Cahill, Elizabeth R. Gerstner, Kristen E. Pauken, Corey M. Gill, Priscilla K. Brastianos, William T. Curry, Michael White, Michael Davies, Husain Danish, Maria Martinez-Lage, Scott L. Carter, Osmaan Shahid, Matthew P. Frosch, Magali De Sauvage, Genevieve M. Boland, Jackson Stocking, Benjamin M. Kuter, Alexander Kaplan, Samuel Markson, Andrew W. Navia, Ashish Dahal, Benjamin Izar, Brian V. Nahed, Brian C. Miller, Ryan J. Sullivan, Naema Nayyar, Nancy Wang, McKenzie Shaw, Megha Subramanian, Matthew R. Strickland, Joana L. Mora, Dennie T. Frederick, Albert E. Kim, Mia Bertalan, Brian A. Shaw
Melanoma-derived brain metastases (MBM) represent an unmet clinical need due to central nervous system (CNS) progression as a frequent, end-stage site of disease. Immune checkpoint inhibition (ICI) represents a clinical opportunity against MBM; howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0483dd667ef7575db2e923007376e7ef
https://doi.org/10.1101/2021.08.25.456956
https://doi.org/10.1101/2021.08.25.456956